The role of chemotherapy in the management of mesothelioma

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

44.6 Conclusions: Several chemotherapy agents have shown minor activity in MPM. Most of the studies supporting their use as single agents or in combination are misleading because of the sample size, lack of uniform measures of response, and lack of reproducibility. However, the combination of cisplatin with pemetrexed has demonstrated improved survival in phase III studies and is now considered standard therapy for mesothelioma.

Original languageEnglish (US)
Title of host publicationTumors of the Chest: Biology, Diagnosis and Management
PublisherSpringer Berlin Heidelberg
Pages515-524
Number of pages10
ISBN (Print)6293603618, 9783540310396
DOIs
StatePublished - 2006

Fingerprint

Pemetrexed
Mesothelioma
Sample Size
Cisplatin
Drug Therapy
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Molina, J. R., & Adjei, A. (2006). The role of chemotherapy in the management of mesothelioma. In Tumors of the Chest: Biology, Diagnosis and Management (pp. 515-524). Springer Berlin Heidelberg. https://doi.org/10.1007/3-540-31040-1_44

The role of chemotherapy in the management of mesothelioma. / Molina, Julian R; Adjei, Alex.

Tumors of the Chest: Biology, Diagnosis and Management. Springer Berlin Heidelberg, 2006. p. 515-524.

Research output: Chapter in Book/Report/Conference proceedingChapter

Molina, JR & Adjei, A 2006, The role of chemotherapy in the management of mesothelioma. in Tumors of the Chest: Biology, Diagnosis and Management. Springer Berlin Heidelberg, pp. 515-524. https://doi.org/10.1007/3-540-31040-1_44
Molina JR, Adjei A. The role of chemotherapy in the management of mesothelioma. In Tumors of the Chest: Biology, Diagnosis and Management. Springer Berlin Heidelberg. 2006. p. 515-524 https://doi.org/10.1007/3-540-31040-1_44
Molina, Julian R ; Adjei, Alex. / The role of chemotherapy in the management of mesothelioma. Tumors of the Chest: Biology, Diagnosis and Management. Springer Berlin Heidelberg, 2006. pp. 515-524
@inbook{cb72603319e745e39af580d4d9329762,
title = "The role of chemotherapy in the management of mesothelioma",
abstract = "44.6 Conclusions: Several chemotherapy agents have shown minor activity in MPM. Most of the studies supporting their use as single agents or in combination are misleading because of the sample size, lack of uniform measures of response, and lack of reproducibility. However, the combination of cisplatin with pemetrexed has demonstrated improved survival in phase III studies and is now considered standard therapy for mesothelioma.",
author = "Molina, {Julian R} and Alex Adjei",
year = "2006",
doi = "10.1007/3-540-31040-1_44",
language = "English (US)",
isbn = "6293603618",
pages = "515--524",
booktitle = "Tumors of the Chest: Biology, Diagnosis and Management",
publisher = "Springer Berlin Heidelberg",

}

TY - CHAP

T1 - The role of chemotherapy in the management of mesothelioma

AU - Molina, Julian R

AU - Adjei, Alex

PY - 2006

Y1 - 2006

N2 - 44.6 Conclusions: Several chemotherapy agents have shown minor activity in MPM. Most of the studies supporting their use as single agents or in combination are misleading because of the sample size, lack of uniform measures of response, and lack of reproducibility. However, the combination of cisplatin with pemetrexed has demonstrated improved survival in phase III studies and is now considered standard therapy for mesothelioma.

AB - 44.6 Conclusions: Several chemotherapy agents have shown minor activity in MPM. Most of the studies supporting their use as single agents or in combination are misleading because of the sample size, lack of uniform measures of response, and lack of reproducibility. However, the combination of cisplatin with pemetrexed has demonstrated improved survival in phase III studies and is now considered standard therapy for mesothelioma.

UR - http://www.scopus.com/inward/record.url?scp=84892825846&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892825846&partnerID=8YFLogxK

U2 - 10.1007/3-540-31040-1_44

DO - 10.1007/3-540-31040-1_44

M3 - Chapter

SN - 6293603618

SN - 9783540310396

SP - 515

EP - 524

BT - Tumors of the Chest: Biology, Diagnosis and Management

PB - Springer Berlin Heidelberg

ER -